Document is current
Any future updates will be listed below
-
Authors
Robert, Marie G
Swale, Christopher https://orcid.org/0000-0002-9739-7774
Pachano, Belen
Dépéry, Léa
Bellini, Valeria
Dard, Céline
Cannella, Dominique
Corrao, Charlotte
Belmudes, Lucid
Couté, Yohann https://orcid.org/0000-0003-3896-6196
Bougdour, Alexandre https://orcid.org/0000-0002-5895-0020
Pelloux, Hervé
Chapey, Emmanuelle https://orcid.org/0000-0002-6620-2567
Wallon, Martine https://orcid.org/0000-0001-8285-8550
Brenier-Pinchart, Marie-Pierre https://orcid.org/0000-0003-1366-5856
Hakimi, Mohamed-Ali https://orcid.org/0000-0002-2547-8233
-
Funding
Funding for this research was provided by:
MSD Avenir (Project LatentToxoDiag,DS-2022-0017)
Agence Nationale de la Recherche (Project Chairs of Excellence in Biology/Health,Project ToxoNeoSex,ANR-24-CHBS-0008)
Agence Nationale de la Recherche (Project ApiMORCing,ANR-21-CE15-0002-01)
Agence Nationale de la Recherche (Project ApiNewDrug,ANR-21-CE35-0010-01)
Agence Nationale de la Recherche (Laboratoire d'Excellence (LabEx) ParaFrap [ANR-11-LABX-0024])
Agence Nationale de la Recherche (Proteomics French Infrastructure,ANR-10-INBS-08)
Agence Nationale de la Recherche (ANR-17-EURE-0003)
Agence Nationale de la Recherche (ANR-10-INBS-0005-02)
Agence Nationale de la Recherche (ANR-17-EURE-0003)
- License Information
-
More Information
Article History
Received: 4 December 2024
Revised: 7 May 2025
Accepted: 8 May 2025
First Online: 19 May 2025
Disclosure and competing interests statement
: MAH, CD, CS, HP, and MPBP are co-inventors of patent PCT/EP2020/081638, covering the use of BCLA as a biomarker for diagnosing chronic toxoplasmosis in humans. MAH, MGR, CS, and MPBP are also co-inventors of a related patent application on using BSM for the same purpose (patent EP24307283.2). Inserm and its subsidiary, Inserm-Transfert, are involved in the patent application. The remaining authors declare no competing interests.
